DK3085363T3 - Lægemiddelindgivelsesindretning til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade - Google Patents

Lægemiddelindgivelsesindretning til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade Download PDF

Info

Publication number
DK3085363T3
DK3085363T3 DK16154811.0T DK16154811T DK3085363T3 DK 3085363 T3 DK3085363 T3 DK 3085363T3 DK 16154811 T DK16154811 T DK 16154811T DK 3085363 T3 DK3085363 T3 DK 3085363T3
Authority
DK
Denmark
Prior art keywords
bupivacaine
local anesthesia
drug
collagen
analgesia
Prior art date
Application number
DK16154811.0T
Other languages
English (en)
Inventor
Michael Myers
Philip Wallace Reginald
Original Assignee
Innocoll Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE2007/0220A external-priority patent/IE85880B1/en
Priority claimed from US11/692,337 external-priority patent/US20080241243A1/en
Application filed by Innocoll Pharm Ltd filed Critical Innocoll Pharm Ltd
Application granted granted Critical
Publication of DK3085363T3 publication Critical patent/DK3085363T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (14)

1. Lægemiddelindgivelsesindretning egnet til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade på et sted i et menneske eller dyr med behov derfor, idet indretningen omfatter en fibrillær kollagenmatrix; og mindst et lægemiddel, idet det mindst ene lægemiddel er i alt væsentligt homogent dispergeret i kollagenmatricen, hvor lægemiddelindgivelsesindretningen omfatter en eller flere frysetørrede kollagensvampe, som indeholder i alt 250 mg eller 200 mg af vandfri bupivacain-hydroklorid.
2. Lægemiddelindgivelsesindretning ifølge krav 1, hvor, når mennesket eller dyret har behov for lokalanalgesi, lokalanæstesi eller nerveblokade efter gastrointestinal (GI) kirurgi, da omfatter lægemiddelindgivelsesindretningen en flerhed af svampe, som indeholder i alt 200 mg bupivacain-hydroklorid, hvor svampene har et overfladeareal på 100 cm2 og en dybde eller tykkelse på 0,5 cm.
3. Indretning ifølge kravene 1-2, hvor analgesi tilvejebringes uden bivirkninger associeret med toksicitet fra lægemiddelindgivelsesindretningen.
4. Indretning ifølge kravene 1-3, hvor indretningen reducerer patientens behovfor systemisk analgesi.
5. Anvendelse afen lægemiddelindgivelsesindretning omfattende en fibrillær kollagenmatrix; og mindst et lægemiddel, idet det mindst ene lægemiddel er i alt væsentligt homogent dispergeret i kollagenmatrixen til fremstillingen af et medikament til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i mennesket eller dyret med behov derfor, idet analgesien, anæstesien eller nerveblokaden omfatter at indgive medikamentet på stedet i et menneske eller dyr med behov derfor, hvor lægemiddelindgivelsesindretningen omfatter en eller flere frysetørrede kollagensvampe, som indeholder i alt 250 mg eller 200 mg af vandfri bupivacain-hydroklorid.
6. Anvendelse ifølge krav 5, hvor mindst en svamp placeres tilstødende det kirurgiske sted, mindst en svamp placeres på tværs af indsnittet i væggen af kropshulrummet og mindst en svamp placeres mellem hinden og huden rundt om indsnittet.
7. Anvendelse ifølge krav 6, hvor anvendelsen er til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i et menneske efter en laparotomi.
8. Anvendelse ifølge kravene 6-7, hvor anvendelsen er til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i et menneske efter ortopædisk, abdominal, gynækologisk eller torakale kirurgiske procedurer.
9. Anvendelse ifølge krav 8, hvor anvendelsen er til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i et menneske efter godartet abdominale eller torakale kirurgiske procedurer.
10. Anvendelse ifølge krav 9, hvor anvendelsen er til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i et menneske efter abdominale hysterektomier, myomektomi og adneks kirurgi.
11. Indretning ifølge kravene 1-4 eller anvendelsen ifølge kravene 5-10, hvor svampene har en dybde på 0,5 cm.
12. Indretning ifølge kravene 1-4 eller anvendelsen ifølge kravene 5-10, hvor hver svamp har en længde på 5 cm og bredde på 5 cm.
13. Anvendelse ifølge kravene 5-10, hvor analgesi tilvejebringes uden bivirkninger associeret med toksicitet fra lægemiddelindgivelsesindretningen.
14. Anvendelse ifølge kravene 5-10, hvor indretningen reducerer patientens behov for systemisk analgesi.
DK16154811.0T 2007-03-28 2008-03-28 Lægemiddelindgivelsesindretning til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade DK3085363T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE2007/0220A IE85880B1 (en) 2007-03-28 A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
US11/692,337 US20080241243A1 (en) 2007-03-28 2007-03-28 Drug delivery device for providing local analgesia, local anesthesia or nerve blockade
EP08719893.3A EP2139457B1 (en) 2007-03-28 2008-03-28 A drug delivery device for providing local analgesia, local anesthesia or nerve blockade

Publications (1)

Publication Number Publication Date
DK3085363T3 true DK3085363T3 (da) 2019-04-29

Family

ID=39540798

Family Applications (2)

Application Number Title Priority Date Filing Date
DK16154811.0T DK3085363T3 (da) 2007-03-28 2008-03-28 Lægemiddelindgivelsesindretning til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade
DK08719893.3T DK2139457T3 (da) 2007-03-28 2008-03-28 Lægemiddelafgivelsesindretning til at tilvejebringe lokal analgesi, lokal anæstesi eller nerveblokade

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK08719893.3T DK2139457T3 (da) 2007-03-28 2008-03-28 Lægemiddelafgivelsesindretning til at tilvejebringe lokal analgesi, lokal anæstesi eller nerveblokade

Country Status (15)

Country Link
EP (2) EP3085363B1 (da)
JP (1) JP5372905B2 (da)
CY (2) CY1117814T1 (da)
DE (1) DE202008018583U1 (da)
DK (2) DK3085363T3 (da)
ES (2) ES2718542T3 (da)
HR (2) HRP20160743T1 (da)
HU (2) HUE043185T2 (da)
IE (1) IES20080229A2 (da)
LT (1) LT3085363T (da)
PL (2) PL2139457T3 (da)
PT (2) PT2139457T (da)
SI (2) SI2139457T1 (da)
TR (1) TR201905174T4 (da)
WO (1) WO2008117268A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE47826E1 (en) 2007-03-28 2020-01-28 Innocoll Pharmaceuticals Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
EP2352531A2 (en) * 2008-11-06 2011-08-10 Innocoll Technologies Limited Drug delivery implants and processes for their preparation
US8858983B2 (en) 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
EP3613413A1 (en) * 2011-12-05 2020-02-26 Incept, LLC Medical organogel processes and compositions
PL2802624T3 (pl) 2012-01-09 2018-02-28 Innocoll Pharmaceuticals Limited Zmodyfikowany kolagen
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
JP6363115B2 (ja) * 2013-02-28 2018-07-25 ミラ ファーマ コーポレイション 注射可能局所麻酔半固体製剤およびその組成物
RU2561301C1 (ru) * 2014-10-06 2015-08-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный аграрный университет имени П.А. Столыпина" Способ трансфеморальной блокады нервов мочевого пузыря у мелких животных
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
AU2022213016A1 (en) * 2021-02-01 2023-08-24 Massey University Post-operative pain management
WO2022219179A1 (en) * 2021-04-15 2022-10-20 Innocoll Pharmaceuticals Limited Drug-release implant for soft tissue surgery
WO2023006922A2 (en) * 2021-07-28 2023-02-02 Innocoll Pharmaceuticals Limited Bupivacaine-collagen drug delivery implant and methods of making and using thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4125400C2 (de) * 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
JPH08143449A (ja) * 1994-11-17 1996-06-04 Lederle Japan Ltd 徐放性局所麻酔用注射剤
US7119062B1 (en) * 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20080124400A1 (en) * 2004-06-24 2008-05-29 Angiotech International Ag Microparticles With High Loadings Of A Bioactive Agent
LT2767292T (lt) * 2004-09-17 2016-12-12 Durect Corporation Palaikomosios vietinės anestezijos mišinys su saib
UA88321C2 (ru) * 2004-09-30 2009-10-12 Ковалон Текнолоджиз Инк. Неадгезивные эластичные желатиновые матрицы

Also Published As

Publication number Publication date
PL3085363T3 (pl) 2019-08-30
PT2139457T (pt) 2016-07-26
PL2139457T3 (pl) 2016-11-30
EP2139457B1 (en) 2016-05-04
CY1121568T1 (el) 2020-05-29
IES20080229A2 (en) 2008-12-24
WO2008117268A3 (en) 2009-03-26
HUE043185T2 (hu) 2019-08-28
HRP20160743T1 (hr) 2016-09-23
WO2008117268A2 (en) 2008-10-02
JP2010522738A (ja) 2010-07-08
HRP20190699T1 (hr) 2019-07-12
SI2139457T1 (sl) 2016-09-30
SI3085363T1 (sl) 2019-07-31
LT3085363T (lt) 2019-06-25
EP2139457A2 (en) 2010-01-06
DE202008018583U1 (de) 2016-03-14
CY1117814T1 (el) 2017-05-17
ES2582368T3 (es) 2016-09-12
ES2718542T3 (es) 2019-07-02
HUE027803T2 (en) 2016-10-28
PT3085363T (pt) 2019-05-16
TR201905174T4 (tr) 2019-05-21
JP5372905B2 (ja) 2013-12-18
EP3085363A1 (en) 2016-10-26
EP3085363B1 (en) 2019-03-20
DK2139457T3 (da) 2016-07-25

Similar Documents

Publication Publication Date Title
DK3085363T3 (da) Lægemiddelindgivelsesindretning til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade
US8034368B2 (en) Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
EP1809329B1 (en) Sustained local anesthetic composition containing saib
JP2004521111A (ja) 局所麻酔薬および使用法
USRE47826E1 (en) Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
US20080241243A1 (en) Drug delivery device for providing local analgesia, local anesthesia or nerve blockade
CA2294950C (en) Levobupivacaine and its use
WO2022219179A1 (en) Drug-release implant for soft tissue surgery
IE20080229U1 (en) A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
IES85185Y1 (en) A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
IE85880B1 (en) A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
IE20070220A1 (en) A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
CN111629713B (zh) 用于治疗手术后疼痛的药物组合物
EP2026814A2 (en) Mirtazapine for the treatment of neuropathic pain
WO2021232157A1 (en) Sustained release pharmaceutical composition
EA044480B1 (ru) Фармацевтическая композиция для лечения послеоперационной боли и способ приготовления такой композиции